These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15869621)

  • 1. The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
    Vossen CY; Rosendaal FR
    J Thromb Haemost; 2005 May; 3(5):1102-3. PubMed ID: 15869621
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.
    Boekholdt SM; Sandhu MS; Wareham NJ; Luben R; Reitsma PH; Khaw KT
    J Thromb Haemost; 2006 Oct; 4(10):2204-9. PubMed ID: 16881935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
    Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
    Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Wells PS; Anderson JL; Rodger MA; Carson N; Grimwood RL; Doucette SP
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):533-8. PubMed ID: 16988547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis.
    Margaglione M; Bossone A; Brancaccio V; Ciampa A; Di Minno G
    Thromb Haemost; 2000 Dec; 84(6):1118-9. PubMed ID: 11154124
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.
    Franco RF; Middeldorp S; Meinardi JR; van Pampus EC; Reitsma PH
    Br J Haematol; 2000 Oct; 111(1):118-21. PubMed ID: 11091190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FXIIIVal34Leu, common and risk factors of venous thrombosis in early middle-age Costa Rican patients.
    Salazar-Sánchez L; Leon MP; Cartin M; Schuster G; Wulff K; Schröder W; Jiménez-Arce G; Chacon R; Herrmann FH
    Cell Biochem Funct; 2007; 25(6):739-45. PubMed ID: 17195962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII polymorphisms and venous thromboembolism.
    Francis CW
    Arch Pathol Lab Med; 2002 Nov; 126(11):1391-3. PubMed ID: 12421147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
    Catto AJ; Kohler HP; Coore J; Mansfield MW; Stickland MH; Grant PJ
    Blood; 1999 Feb; 93(3):906-8. PubMed ID: 9920839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
    Renner W; Köppel H; Hoffmann C; Schallmoser K; Stanger O; Toplak H; Wascher TC; Pilger E
    Thromb Res; 2000 Jul; 99(1):35-9. PubMed ID: 10904101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the Factor XIII Val34Leu Polymorphism in Korean Patients with Deep Vein Thrombosis.
    Kim SD; Hwang JK; Park SC; Kim JI; Won YS; Yun SS; Moon IS; Park JS
    Ann Vasc Surg; 2016 Apr; 32():57-64. PubMed ID: 26802299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
    Cieśla-Dul M; Gaweda B; Wypasek E; Rózańska M; Sadowski J
    Pol Arch Med Wewn; 2009 Dec; 119(12):822-5. PubMed ID: 20010469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIIIV34L is not an additional genetic risk for venous thrombosis in factor V Leiden carriers.
    Morange PE; Henry M; Brunet D; Aillaud MF; Juhan-Vague I
    Blood; 2001 Mar; 97(6):1894-5. PubMed ID: 11263439
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
    Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
    Diz-Kucukkaya R; Hancer VS; Inanc M; Nalcaci M; Pekcelen Y
    Lupus; 2004; 13(1):32-5. PubMed ID: 14870915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.